Life expectancy in developed nations is continuing to increase by 6 hr a day, presenting a profound challenge for the organization of society. At the same time, science is at last beginning to unravel the deep mysteries of the aging process and create new possibilities for translational research that might deliver innovative therapies for age‐related disease. Evidence from many lines of research confirms that aging is more malleable than thought previously, since it arises not from a strict genetic program but from the gradual accumulation of damage in cells and tissues of the body, which can be modulated in turn by many factors including nutrition, lifestyle, and environment. The relationship between the intrinsic biology of aging and wellbeing in later life is of high importance, yet is complex. Old age is associated with significant multimorbidity, so the presence of age‐related diseases in those at advanced old age (for example, over 85) is normal. Since age is the single biggest risk factor for a very wide spectrum of diseases, which individually attract major research effort, the prize of identifying exactly why aged cells are more vulnerable to pathology, and thereby how such pathology might be delayed or prevented, seems eminently worthwhile. Yet, in spite of experiencing an average of four or five age‐related conditions simultaneously, the majority (nearly 80%) of participants in a large, recent study self‐reported their health as “good,” “very good,” or “excellent.”